Comment on "Impact of Routine Clinic Measurement of Random Serum C-peptide in People with a Clinician Diagnosis of Type 1 Diabetes"
We commend Foteinopoulou and colleagues on their efforts to determine the impact of random serum C-peptide measurements on diagnosis and treatment in clinically diagnosed type 1 diabetes (T1D) individuals. We agree that there is a role for the incorporation of C-peptide in the diagnostic algorithm of T1D.
|ISBN||1464-5491 (Electronic) 0742-3071 (Linking)|
|Authors||Patel, S. K.; Fourlanos, S.; Greenfield, J. R.|
|Responsible Garvan Author||Prof Jerry Greenfield|
|Publisher Name||DIABETIC MEDICINE|
|URL link to publisher's version||https://www.ncbi.nlm.nih.gov/pubmed/33415774|